Does APIXABAN Cause Hepatitis cholestatic? 50 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hepatitis cholestatic have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
50
Reports of Hepatitis cholestatic with APIXABAN
0.0%
of all APIXABAN reports
1
Deaths
37
Hospitalizations
How Dangerous Is Hepatitis cholestatic From APIXABAN?
Of the 50 reports, 1 (2.0%) resulted in death, 37 (74.0%) required hospitalization.
Is Hepatitis cholestatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Hepatitis cholestatic?
ATORVASTATIN (396)
ACETAMINOPHEN (356)
AMOXICILLIN\CLAVULANATE (190)
PANTOPRAZOLE (184)
AMOXICILLIN\CLAVULANIC ACID (178)
SULFAMETHOXAZOLE\TRIMETHOPRIM (143)
TACROLIMUS (119)
IBUPROFEN (110)
LEVOFLOXACIN (110)
PEMBROLIZUMAB (110)
Which APIXABAN Alternatives Have Lower Hepatitis cholestatic Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ